Avicanna Announces Changes of Auditors
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and com…
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and com…